{
  "url": "https://openlegislation.uk/controlled-drugs-supervision-of-management-and-use-regulations-2013/regulation-6",
  "json_url": "https://openlegislation.uk/controlled-drugs-supervision-of-management-and-use-regulations-2013/regulation-6.json",
  "legislation": "uksi/2013/373",
  "legislation_title": "The Controlled Drugs (Supervision of Management and Use) Regulations 2013",
  "legislation_url": "https://openlegislation.uk/controlled-drugs-supervision-of-management-and-use-regulations-2013",
  "path": "regulation/6",
  "kind": "regulation",
  "number": "6",
  "heading": "Meaning of “responsible bodies”",
  "text": "For the purposes of these Regulations, the following are responsible bodies—\n(a) as regards England and Scotland, the regulatory bodies;\n(b) as regards England—\n(i) designated bodies in England,\n(ii) integrated care boards,\n(iii) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .\n(iv) ... the NHSBSA,\n(v) the CQC,\n(vi) local authorities in England, and\n(vii) police forces in England; and\n(c) as regards Scotland—\n(i) designated bodies in Scotland,\n(ii) the Scottish Counter Fraud Services,\n(iii) Public Health Scotland,\n(iv) the Practitioner Services Division of the Common Services Agency,\n(v) HIS,\n(vi) the Care Inspectorate,\n(vii) local authorities in Scotland, and\n(viii) the police force in Scotland.",
  "extent": "E+W+S",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Words in Regulations substituted (1.7.2022) by The Health and Care Act 2022 (Consequential and Related Amendments and Transitional Provisions) Regulations 2022 (S.I. 2022/634), reg. 1(2), Sch. para. 1(1)(3) (with Sch. para. 1(2))"
    },
    {
      "type": "F",
      "label": "F2",
      "text": "Reg. 6(b)(iii) omitted (1.4.2020) by virtue of The Controlled Drugs (Supervision of Management and Use) (Amendment) Regulations 2020 (S.I. 2020/189), regs. 1(2)(b), 6(a)(i)"
    },
    {
      "type": "F",
      "label": "F3",
      "text": "Words in reg. 6(b)(iv) omitted (1.4.2020) by virtue of The Controlled Drugs (Supervision of Management and Use) (Amendment) Regulations 2020 (S.I. 2020/189), regs. 1(2)(b), 6(a)(ii)"
    },
    {
      "type": "F",
      "label": "F4",
      "text": "Reg. 6(c)(iii) substituted (1.4.2020) by The Controlled Drugs (Supervision of Management and Use) (Amendment) Regulations 2020 (S.I. 2020/189), regs. 1(2)(b), 6(b)"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2013/373/regulation/6",
    "retrieved_at": "2026-10-29T01:03:40.514066+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}